Footlocker got a Stimmy it enough?

May 20, 2021

Footlocker got a Stimmy it enough?

Footlocker may be the purest example of a stimulus injection moving the needle for a company in our coverage universe.

In 2020, we watched a massive increase in Mention volume following the first round of government stimulus checks. FL same-store sales unexpectedly increased by +18% YoY and shares rallied.

However, as our data shows, this injection was short-lived. Buzz retreated to 2019 average levels by October 2020, and again earlier this year.

Recently, we recorded a familiar volume increase....right alongside additional rounds of government stimulus. You can see this reflected in tweets, like this -- and this.

Buzz is currently pacing +37% QoQ, but is normalizing as stimulus infusions dry up.

Another potential driver for unexpected upside in 2021 is the return of foot traffic to malls. Mall shopping mentions are +13% YoY -- but there's not a tough comparison bar.

While FL may suprise investors on its current report, data suggests this is a short-term blip. Footlocker has a lot of ground to make up and is located in an increasingly tough spot.

Consumer happiness is significantly lower than peers at 46% positive vs. NKE at 61% positive.

And analysts have described Nike's DTC offense as being "on steroids".

If you're a middleman like Footlocker, this isn't music to your ears -- NKE accounts for 75% of all merchandise purchased.

Want deeper insights? Get Free Access to The Vault.

Related Posts

You down with DTC? (ya you know me!)

Nike reported an awesome quarter Tuesday evening.  The stock is […]

Read More
Can Footlocker deliver another earnings surprise?

Footlocker (FL) Last quarter, Footlocker stole our thunder when it […]

Read More
Can DTC Strength Bolster Nike’s Earnings? ($NKE)

Can DTC Strength Bolster Nike’s Earnings? ($NKE) Since the outset […]

Read More
1 2 3 7

Related Posts

About LikeFolio

LikeFolio analyzes social media data to accurately predict shifts in consumer behavior. We sell data and insights to professional investors, corporate research teams, and software providers.
© 2024
 LikeFolio. All Rights Reserved.